Newly FDA Approved Alzheimer’s Biomarkers Testing: How to Implement Such Tests in Core Laboratory?

Newly FDA Approved Alzheimer’s Biomarkers Tes...

AMERICAN SOCIETY FOR CLINICAL PATHOLOGYAMERICAN SOCIETY FOR CLINICAL PATHOLOGY

Up next

Rethinking Cervical Cancer Screening in a Changing Diagnostic Landscape

In this episode of Inside the Lab, Patricia Delgado and Liz Etkin-Kramer explore the evolving landscape of cervical cancer screening amid recent guideline updates emphasizing primary HPV testing, self-collection, and revised screening exit criteria. The conversation examines the ...  Show more

 . 54min 53sec
Annual Meeting Special Episode – Workforce and Recruitment in Pathology

Recorded live at the 2025 ASCP Annual Meeting in Atlanta, this special episode of Inside the Lab brings together a diverse panel—a practicing pathologist, two medical students, and a resident—to explore one of the profession’s most urgent challenges: the pathology workforce short ...  Show more

 . 43min 40sec

Recommended Episodes

Diagnosis of Alzheimer Disease Using Plasma Biomarkers
Neurology® Podcast

Dr. Greg Cooper talks with Dr. Joseph Therriault about the use of plasma biomarkers in diagnosing Alzheimer disease, emphasizing the importance of interpreting these biomarkers within the clinical context of the patient. Read the related article in Nature. Disclosures can be foun ...  Show more

 . 21min 31sec
Biomarkers: Detecting Alzheimer's Early Enough to Treat it.
Understanding Alzheimer's and Dementia: Oxford ARUK Public Open Day

What are Biomarkers? And why are they useful in Alzheimer's Disease Research. 

 . 21min 55sec
Liana G. Apostolova, MS, MD, FAAN - Accelerating Progress in the Treatment of Alzheimer’s Disease: How Can We Achieve Timely and Accurate Neuropathological Diagnosis and Precision Management of Mild Cognitive Impairment in Early Alzheimer’s Disease?
PeerView Internal Medicine CME/CNE/CPE Audio Podcast

Go online to PeerView.com/JYU860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. Alzheimer’s disease (AD) is a devastating, progressive neurodegenerative disorder affecting 10% of people over age 65 and increasing in global prev ...  Show more

 . 1h 44min
Should You Get a Blood Test For Alzheimer's?
Science Quickly

Consumers can now get easy tests for Alzheimer’s. But these tests may not really help patients that much—yet. Learn more about your ad choices. Visit megaphone.fm/adchoices 

 . 10min 31sec